🇫🇷 🇧🇪

Exit

Sector: Life Sciences
Fund: Club I
Team: Dominique Surleraux

Description

BCI Pharma is a company existing for 5 years in Montpellier, France. It has been relocated partly to Liège following a 3MM capital increase led by TheClubDeal. It has developed proofs of concepts in Biotech research on neuropathic pains, on a medical development articulated on kinase inhibitors, highly potent and targeted molecules.The business model consist in creating partnerships with larger players at early stage so to jointly develop applications and related cures and drug development.

Company News

L’ECHO : Gedeon Richter reprend la biotech liégeoise BCI Pharma

L’ECHO : Gedeon Richter reprend la biotech liégeoise BCI Pharma

Read more

L’ECHO : BCI Pharma, la petite biotech liégeoise aux grandes ambitions

L’ECHO : BCI Pharma, la petite biotech liégeoise aux grandes ambitions

Read more

L’ECHO: La biotech française BCI Pharma se relocalise en Wallonie

L’ECHO: La biotech française BCI Pharma se relocalise en Wallonie

Read more

BCI Pharma (Montpellier) lève 3,9 millions d’euros

BCI Pharma (Montpellier) lève 3,9 millions d’euros

Read more

L’ECHO: Près de 4 millions pour faire croître BCI Pharma

L’ECHO: Près de 4 millions pour faire croître BCI Pharma

Read more

Investment Managers

Other investments in Life Sciences

Other investments in Club I

Subscribe to our Newsletter

We seek to customise the content to the segments we serve.

These are both fund investors and the entrepreneurs with whom we have created alliances.

We are happy to keep in touch.

Newsletter Form (#56)